Over the past two decades a wealth of information has been acquired on various factors that may interfere with effective anti-tumour immune responses such as Tregs, cytokines, tumour matrix, immunological checkpoint receptors (PD-1, CTLA-4) and others22. Here, CTLA4 is linked to neoplasm.